Table 3. Review of human studies using robotic bronchoscopy platforms.
| Author, year | Type of study | Patients (n) | Mean/median diameter (mm) | SD/IQR or range | Nodules sampled (n) | Diagnostic yield (%) |
|---|---|---|---|---|---|---|
| Ion™ Robotic Endoluminal System | ||||||
| Fernandez-Bussy 2024, (12) | Retrospective | 22 | 14 | IQR, 1–2 | 46 | 86.9 |
| Fernandez-Bussy 2024, (13) | Retrospective | 27 | 16.6 | IQR, 13.6–19.9 | 28 | 85.7 |
| Abia-Trujillo 2024, (10) | Retrospective | 173 | 12 | IQR, 10–14 | 192 | 77.4 |
| Abia-Trujillo 2023, (11) | Retrospective | 22 | 18 | IQR, 14–20 | 23 | 88.9 |
| Gupta 2023, (14) | Abstract prospective | 240 | 16 | IQR, 1.1–25 | 265 | 76 |
| Hammad Altaq 2023, (15) | Retrospective | 42 | 12 | IQR, 10–18 | 42 | 88.1 |
| Low 2023, (16) | Retrospective | 133 | 19 | IQR, 14–28 | 143 | 77 |
| Chambers 2023, (17) | Retrospective | 75 | 20 | IQR, 13–35 | 79 | 77.2 |
| Styrvoky 2022, (9) | Retrospective | 198 | 22.6 | SD: 13.3 | 209 | 91.4 |
| Oberg 2022, (18) | Retrospective | 112 | 22 | IQR, 13–34.3 | 120 | 90 |
| Yu Lee-Mateus 2023, (19) | Retrospective | 113 | 18 | IQR, 13–27 | 113 | 87.6 |
| Reisenauer 2022, (20) | Prospective | 30 | 17.5 | SD: 6.8 | 30 | 93.3 |
| Tavakoli 2022, (21) | Abstract retrospective | 65 | 21.2 | SD: NA | 65 | 86.2 |
| Kalchiem-Dekel 2022, (8) | Prospective | 130 | 18 | IQR, 13–27 | 159 | 81.7 |
| Ost 2021(22) | Abstract prospective | 155 | 17 | SD: 5.5 | 155 | 83 |
| Benn 2021, (7) | Prospective | 52 | 19.6 | SD: 10.9 | 59 | 83 |
| Ross 2021, (23) | Abstract prospective | 45 | 14 | Range, 5–44 | 58 | 89 |
| Bawek 2021, (24) | Abstract retrospective | 76 | 17 | Range, 6–70 | 76 | 92 |
| Ghosh 2021, (25) | Abstract retrospective | 95 | 19 | Range, 7–69 | 103 | 79.6 |
| Pritchett 2021, (26) | Abstract retrospective | 192 | 15 | IQR, 10–21 | 230 | 92.2 |
| Folch 2020, (27) | Abstract prospective | 129 | 18.4 | SD: 5.44 | 129 | 80.6 |
| Fielding 2019, (6) | Prospective | 29 | 12.2 | SD: 4.2 | 29 | 79.3 |
| Monarch™ Robotic Endoscopy System | ||||||
| Agrawal 2023, (28) | Retrospective | 124 | 24 | IQR, 13–30 | 124 | 77 |
| Khan 2023, (29) | Retrospective | 264 | 19.3 | Range, 32–72.5 | 264 | 85.2 |
| Manley 2023, (30) | Prospective | 20 | 14.5 | Range, 8–28 | 20 | 80 |
| Hedstrom 2022, (31) | Abstract retrospective | 45 | 16.9 | Range, 4–35 | 45 | 91 |
| Cumbo-Nacheli 2022, (32) | Retrospective | 20 | 22 | SD: 7 | 20 | 90 |
| Chen 2021, (33) | Prospective | 54 | 23.2 | SD: 10.8 | 54 | 82.5 |
| Ekeke 2021, (34) | Retrospective | 25 | NA | NA | 25 | 96 |
| Chaddha 2019, (35) | Retrospective | 165 | 25 | SD: 15 | 167 | 77 |
| Rojas-Solano 2018, (36) | Prospective | 15 | 26 | Range, 10–63 | 15 | 86.7 |
| Galaxy™ Robotic Endoscopy System | ||||||
| Saghaie 2023, (37) | Abstract Prospective | 14 | 20.5 | Range, 10–34 | 15 | 93 |
SD, standard deviation; IQR, interquartile range; NA, not available.